Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial
Journal of Rheumatology, 36(8):1705-1714
Lectura recomendada:
Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist Up to One Year Following Discontinuing Treatment
Journal of Clinical Endocrinology and Metabolism, 95(2):559-566
Lectura recomendada:
Low Bone Mass and High Bone Turnover in Postmenopausal Human Immunodeficiency Virus-Infected Women
Journal of Clinical Endocrinology and Metabolism, 95(2):620-629
Lectura recomendada:
Efficacy and Tolerability of Once-Monthly Oral Ibandronate (150 mg) and Once-Weekly Oral Alendronate (70 mg): Additional Results from the Monthly Oral Therapy with Ibandronate for Osteoporosis Intervention (MOTION) Study
Clinical Therapeutics, 31(4):751-761
Lectura recomendada:
Assessment of Determinants for Osteoporosis in Elderly Men
Osteoporosis International, 20(7):1157-1166
¿Cuáles son factores de riesgo de osteoporosis?
Introducción:
La osteoporosis es una enfermedad frecuente que genera costos importantes en el sistema de salud. Se estima que afecta a 10 millones de personas en los EE.UU.
Lectura recomendada:
Factors Associated with Diagnosis and Treatment of Osteoporosis in Older Adults
Osteoporosis International, 20(11):1963-1967
Lectura recomendada:
Chronic Obstructive Pulmonary Disease Is Associated with Osteoporosis and Low Levels of Vitamin D
Osteoporosis International, 20(11):1881-1887
Lectura recomendada:
Alendronate Enhances Osteogenic Differentiation of Bone Marrow Stromal Cells
Clinical Orthopaedics and Related Research, 467(12):3121-3128
Lectura recomendada:
Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women
Calcified Tissue International, 85(5):398-404
Lectura recomendada:
Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover MArkers in Korean Postmenopausal Osteoporotic Women
Calcified Tissue International, 85(5):389-397